2015

Featured on 2015

Meeting Lot-Size Challenges of Manufacturing Adherent Cells for Therapy
Sponsored Content
Meeting Lot-Size Challenges of Manufacturing Adherent Cells for TherapyMeeting Lot-Size Challenges of Manufacturing Adherent Cells for Therapy

+3
byJon Rowley, Eytan Abrahamand 3 more
Sep 16, 2015
T-Cell Suspension Culture in a 24-Well Microbioreactor: High-Throughput Screening of Operating Conditions
Sponsored Content
T-Cell Suspension Culture in a 24-Well Microbioreactor: High-Throughput Screening of Operating ConditionsT-Cell Suspension Culture in a 24-Well Microbioreactor: High-Throughput Screening of Operating Conditions
byKenny Choi, Jason N. Carstensand 1 more
Sep 16, 2015
Scaling Up Stem Cells: Moving from Laboratory to Commercial Production with a Single-Use Multiplate Bioreactor
Sponsored Content
Scaling Up Stem Cells: Moving from Laboratory to Commercial Production with a Single-Use Multiplate BioreactorScaling Up Stem Cells: Moving from Laboratory to Commercial Production with a Single-Use Multiplate Bioreactor
byMatthieu Egloff, Jose Castilloand 1 more
Sep 16, 2015
Expansion and Characterization of Mesenchymal Stem Cells on Pall SoloHill® Microcarriers
Sponsored Content
Expansion and Characterization of Mesenchymal Stem Cells on Pall SoloHill® MicrocarriersExpansion and Characterization of Mesenchymal Stem Cells on Pall SoloHill® Microcarriers
byHeather Woolls, David Splanand 1 more
Sep 16, 2015
Strategies for Microcarrier Culture Optimization
Sponsored Content
Strategies for Microcarrier Culture OptimizationStrategies for Microcarrier Culture Optimization
byMark Szczypka, Alain Fairbank
Sep 16, 2015
Designing the Most Cost-Effective Manufacturing Strategy for Allogeneic Cell-Based Therapies
Sponsored Content
Designing the Most Cost-Effective Manufacturing Strategy for Allogeneic Cell-Based TherapiesDesigning the Most Cost-Effective Manufacturing Strategy for Allogeneic Cell-Based Therapies
byThierry Bovy, Alain Fairbankand 1 more
Sep 16, 2015

More from 2015

Production of Viral Vectors Using the iCELLis® Fixed-Bed Bioreactor System: Beyond Mesenchymal Stem Cells — Gene-Modified Cell Therapy, Gene
Sponsored Content
Production of Viral Vectors Using the iCELLis® Fixed-Bed Bioreactor System: Beyond Mesenchymal Stem Cells — Gene-Modified Cell Therapy, Gene Therapy, and Exosomes
Production of Viral Vectors Using the iCELLis® Fixed-Bed Bioreactor System: Beyond Mesenchymal Stem Cells — Gene-Modified Cell Therapy, Gene Therapy, and Exosomes
Sep 16, 2015
byMatt Kremer
Single-Use Bioreactors and Microcarriers: Scalable Technology for Cell-Based Therapies
Sponsored Content
Single-Use Bioreactors and Microcarriers: Scalable Technology for Cell-Based Therapies
Single-Use Bioreactors and Microcarriers: Scalable Technology for Cell-Based Therapies
Sep 16, 2015
+2
byMark Szczypka, David Splanand 2 more
Ask the Experts: Core Technologies Expand Opportunities for Cell Therapy Manufacturing
Sponsored Content
Ask the Experts: Core Technologies Expand Opportunities for Cell Therapy Manufacturing
Ask the Experts: Core Technologies Expand Opportunities for Cell Therapy Manufacturing
Sep 16, 2015
byS. Anne Montgomery
Positioning Tools, Technologies, and Talents for Cell Therapies: An Interview with Harvey Brandwein
Sponsored Content
Positioning Tools, Technologies, and Talents for Cell Therapies: An Interview with Harvey Brandwein
Positioning Tools, Technologies, and Talents for Cell Therapies: An Interview with Harvey Brandwein
Sep 16, 2015
byBrian Caine, S. Anne Montgomery
Featured Products and Services
Sponsored Content
Featured Products and Services
Featured Products and Services
Sep 16, 2015
byBPI Staff
From the Editor - August 2015 Supplement logo in a gray background | From the Editor - August 2015 Supplement
Business
From the Editor - August 2015 Supplement
From the Editor - August 2015 Supplement
Aug 24, 2015
byS. Anne Montgomery
Formulation/Fill–Finish: BPI Theater @ BIO 2015 logo in a gray background | Formulation/Fill–Finish: BPI Theater @ BIO 2015
Fill/Finish
Formulation/Fill–Finish: BPI Theater @ BIO 2015
Formulation/Fill–Finish: BPI Theater @ BIO 2015
Aug 24, 2015
+1
byMatt Feldman, Greg Adamsand 1 more
Manufacturing Strategies: BPI Theater @ Interphex 2015 logo in a gray background | Manufacturing Strategies: BPI Theater @ Interphex 2015
Risk Management
Manufacturing Strategies: BPI Theater @ Interphex 2015
Manufacturing Strategies: BPI Theater @ Interphex 2015
Aug 24, 2015
+2
byBill Hartzel, Frank Nygaardand 2 more
Clinical/Commercial Manufacturing: BPI Theater @ BIO 2015 logo in a gray background | Clinical/Commercial Manufacturing: BPI Theater @ BIO 2015
Contract Services
Clinical/Commercial Manufacturing: BPI Theater @ BIO 2015
Clinical/Commercial Manufacturing: BPI Theater @ BIO 2015
Aug 24, 2015
+3
byTony Hitchcock, Joe Wypychand 3 more
Choosing Between Single-Use and Multiuse Technologies: A BPI Theater Roundtable at Interphex 2015
Single Use
Choosing Between Single-Use and Multiuse Technologies: A BPI Theater Roundtable at Interphex 2015
Choosing Between Single-Use and Multiuse Technologies: A BPI Theater Roundtable at Interphex 2015
Aug 24, 2015
byCheryl Scott
Single-Use Technologies: BIO Theater @ Interphex 2015 logo in a gray background | Single-Use Technologies: BIO Theater @ Interphex 2015
Single Use
Single-Use Technologies: BIO Theater @ Interphex 2015
Single-Use Technologies: BIO Theater @ Interphex 2015
Aug 24, 2015
+4
byAndrew Lidums, René Gantier, PhDand 4 more
New Approaches to Fill and Finish: A BPI Theater Roundtable at Interphex 2015
Fill/Finish
New Approaches to Fill and Finish: A BPI Theater Roundtable at Interphex 2015
New Approaches to Fill and Finish: A BPI Theater Roundtable at Interphex 2015
Aug 24, 2015
byCheryl Scott
Cell-line/Process Development - BPI Theater @ BIO 2015 logo in a gray background | Cell-line/Process Development - BPI Theater @ BIO 2015
Cell Line Development
Cell-line/Process Development - BPI Theater @ BIO 2015
Cell-line/Process Development - BPI Theater @ BIO 2015
Aug 24, 2015
+4
byRaymond Price, Karen Fallenand 4 more
Managing Contract Relationships: A BPI Theater Roundtable at the 2015 BIO Convention
Contract Services
Managing Contract Relationships: A BPI Theater Roundtable at the 2015 BIO Convention
Managing Contract Relationships: A BPI Theater Roundtable at the 2015 BIO Convention
Aug 24, 2015
byCheryl Scott
Speeding Development and Lowering Costs While Enhancing Quality: A BPI Theater Roundtable at the 2015 BIO Convention
Contract Services
Speeding Development and Lowering Costs While Enhancing Quality: A BPI Theater Roundtable at the 2015 BIO Convention
Speeding Development and Lowering Costs While Enhancing Quality: A BPI Theater Roundtable at the 2015 BIO Convention
Aug 24, 2015
byCheryl Scott
The Contractor Perspective: A BPI Theater Roundtable at the 2015 BIO Convention
Contract Services
The Contractor Perspective: A BPI Theater Roundtable at the 2015 BIO Convention
The Contractor Perspective: A BPI Theater Roundtable at the 2015 BIO Convention
Aug 24, 2015
byCheryl Scott
From the Editor logo in a gray background | From the Editor
Business
From the Editor June 2015
From the Editor June 2015
Jun 16, 2015
byS. Anne Montgomery
Spotlight logo in a gray background | Spotlight
Business
Spotlight June 2015
Spotlight June 2015
Jun 16, 2015
byBPI Staff
Are You Ready for a Tech Transfer? Part 2: Overcoming Obstacles and Implementing Best Practices for Cell Therapy Technology Transfer
Cell Therapies
Are You Ready for a Tech Transfer? Part 2: Overcoming Obstacles and Implementing Best Practices for Cell Therapy Technology Transfer
Are You Ready for a Tech Transfer? Part 2: Overcoming Obstacles and Implementing Best Practices for Cell Therapy Technology Transfer
Jun 16, 2015
byCatherine A. McIntyre, Cenk Sumen
Challenges in Implementing Quality By Design: An Industry Perspective
Process Development
Challenges in Implementing Quality By Design: An Industry Perspective
Challenges in Implementing Quality By Design: An Industry Perspective
Jun 16, 2015
byMichael Torres
Special Report: A World of Difference — Biosimilars and Biobetters Offer Unique Benefits — and Risks
Biosimilars
Special Report: A World of Difference — Biosimilars and Biobetters Offer Unique Benefits — and Risks
Special Report: A World of Difference — Biosimilars and Biobetters Offer Unique Benefits — and Risks
Jun 16, 2015
byCheryl Scott, S. Anne Montgomery
Assessing Similarity with Parallel-Line and Parallel-Curve Models: Implementing the USP Development/Validation Approach to a Relative Potency Assay
Assays
Assessing Similarity with Parallel-Line and Parallel-Curve Models: Implementing the USP Development/Validation Approach to a Relative Potency Assay
Assessing Similarity with Parallel-Line and Parallel-Curve Models: Implementing the USP Development/Validation Approach to a Relative Potency Assay
Jun 16, 2015
+3
byErica Bortolotto, Rejane Rousseauand 3 more
Optimization and Scale-Up of HCIC-Based MAb Purification Processes, Part 2
Chromatography
Optimization and Scale-Up of HCIC-Based MAb Purification Processes, Part 2
Optimization and Scale-Up of HCIC-Based MAb Purification Processes, Part 2
Jun 16, 2015
+3
byStephanie Chaudoreille, Natalie Bohrerand 3 more
Evaluation of a Variable-Pathlength Spectrophotometer: A Comparable Instrument for Determining Protein Concentration
Bioanalytical Methods
Evaluation of a Variable-Pathlength Spectrophotometer: A Comparable Instrument for Determining Protein Concentration
Evaluation of a Variable-Pathlength Spectrophotometer: A Comparable Instrument for Determining Protein Concentration
Jun 16, 2015
+2
byBriana Lehr, John Robinsonand 2 more
Anion-Exchange Chromatographic Clarification: Bringing Simplification, Robustness, and Savings to MAb Purification
Chromatography
Anion-Exchange Chromatographic Clarification: Bringing Simplification, Robustness, and Savings to MAb Purification
Anion-Exchange Chromatographic Clarification: Bringing Simplification, Robustness, and Savings to MAb Purification
Jun 16, 2015
+2
byAngelines A. Castro-Forero, Zona Jokondoand 2 more
An Industrial Platform Solution for Antibody Fragment Purification
Separation/Purification
An Industrial Platform Solution for Antibody Fragment Purification
An Industrial Platform Solution for Antibody Fragment Purification
Jun 16, 2015
byJonathan Royce
Paying for Pricey Medications: Debt Financing Options Could Provide a Solution logo in a gray background | Paying for Pricey Medications: Debt Financing Options Could Provide a Solution
Economics
Paying for Pricey Medications: Debt Financing Options Could Provide a Solution
Paying for Pricey Medications: Debt Financing Options Could Provide a Solution
Jun 16, 2015
bySoeren Mattke
From the Publisher logo in a gray background | From the Publisher
Business
From the Publisher
From the Publisher
May 12, 2015
byBrian Caine
Spotlight: Niche-Disease — Barth Syndrome logo in a gray background | Spotlight: Niche-Disease — Barth Syndrome
Business
Spotlight: Niche-Disease — Barth Syndrome
Spotlight: Niche-Disease — Barth Syndrome
May 12, 2015
byCheryl Scott
Fundamental Strategies for Viral Clearance Part 2: Technical Approaches
Viral Clearance
Fundamental Strategies for Viral Clearance Part 2: Technical Approaches
Fundamental Strategies for Viral Clearance Part 2: Technical Approaches
May 12, 2015
byKathryn Martin Remington

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Ask the Expert webcasts
ATE Webcasts
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe